257 related articles for article (PubMed ID: 27320920)
41. Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex.
Jamali M; Barar E; Shi J
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791111
[TBL] [Abstract][Full Text] [Related]
42. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
Zhang S; Chung WC; Xu K
Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
[TBL] [Abstract][Full Text] [Related]
43. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
[TBL] [Abstract][Full Text] [Related]
44. WDR5 high expression and its effect on tumorigenesis in leukemia.
Ge Z; Song EJ; Kawasawa YI; Li J; Dovat S; Song C
Oncotarget; 2016 Jun; 7(25):37740-37754. PubMed ID: 27192115
[TBL] [Abstract][Full Text] [Related]
45. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
Grippo PJ; Sandgren EP
Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
[TBL] [Abstract][Full Text] [Related]
46. The Histone H3 Lysine 4 Presenter WDR5 as an Oncogenic Protein and Novel Epigenetic Target in Cancer.
Lu K; Tao H; Si X; Chen Q
Front Oncol; 2018; 8():502. PubMed ID: 30488017
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of SOX18 correlates with accelerated cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
Wang Y; Guo H; Zhang D; Yu X; Leng X; Li S; Zhu W
Biochem Biophys Res Commun; 2016 Oct; 479(3):510-516. PubMed ID: 27663663
[TBL] [Abstract][Full Text] [Related]
48. The MYC-WDR5 Nexus and Cancer.
Thomas LR; Foshage AM; Weissmiller AM; Tansey WP
Cancer Res; 2015 Oct; 75(19):4012-5. PubMed ID: 26383167
[TBL] [Abstract][Full Text] [Related]
49. Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors.
Steinhart Z; Pavlovic Z; Chandrashekhar M; Hart T; Wang X; Zhang X; Robitaille M; Brown KR; Jaksani S; Overmeer R; Boj SF; Adams J; Pan J; Clevers H; Sidhu S; Moffat J; Angers S
Nat Med; 2017 Jan; 23(1):60-68. PubMed ID: 27869803
[TBL] [Abstract][Full Text] [Related]
50. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.
He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z
Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622
[TBL] [Abstract][Full Text] [Related]
51. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
52. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
[TBL] [Abstract][Full Text] [Related]
53. Structural analysis of the KANSL1/WDR5/KANSL2 complex reveals that WDR5 is required for efficient assembly and chromatin targeting of the NSL complex.
Dias J; Van Nguyen N; Georgiev P; Gaub A; Brettschneider J; Cusack S; Kadlec J; Akhtar A
Genes Dev; 2014 May; 28(9):929-42. PubMed ID: 24788516
[TBL] [Abstract][Full Text] [Related]
54. WDR5-Myc axis promotes the progression of glioblastoma and neuroblastoma by transcriptional activating CARM1.
Wang F; Zhang J; Ke X; Peng W; Zhao G; Peng S; Xu J; Xu B; Cui H
Biochem Biophys Res Commun; 2020 Mar; 523(3):699-706. PubMed ID: 31948749
[TBL] [Abstract][Full Text] [Related]
55. Loss of Wdr5 attenuates MLL-rearranged leukemogenesis by suppressing Myc targets.
Liu L; Guo X; Wang Y; Li G; Yu Y; Song Y; Zeng C; Ding Z; Qiu Y; Yan F; Zhang YX; Zhao C; Zhang Y; Dou Y; Atadja P; Li E; Wang H
Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166600. PubMed ID: 36402263
[TBL] [Abstract][Full Text] [Related]
56. Structure-based design and synthesis of small molecular inhibitors disturbing the interaction of MLL1-WDR5.
Li DD; Chen WL; Xu XL; Jiang F; Wang L; Xie YY; Zhang XJ; Guo XK; You QD; Sun HP
Eur J Med Chem; 2016 Aug; 118():1-8. PubMed ID: 27116709
[TBL] [Abstract][Full Text] [Related]
57. The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening.
Ye X; Zhang R; Lian F; Zhang W; Lu W; Han J; Zhang N; Jin J; Luo C; Chen K; Ye F; Ding H
Bioorg Med Chem Lett; 2019 Feb; 29(4):638-645. PubMed ID: 30626558
[TBL] [Abstract][Full Text] [Related]
58. Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells.
Abt ER; Le TM; Dann AM; Capri JR; Poddar S; Lok V; Li L; Liang K; Creech AL; Rashid K; Kim W; Wu N; Cui J; Cho A; Lee HR; Rosser EW; Link JM; Czernin J; Wu TT; Damoiseaux R; Dawson DW; Donahue TR; Radu CG
Cell Rep; 2022 Jan; 38(2):110236. PubMed ID: 35021095
[TBL] [Abstract][Full Text] [Related]
59. Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion.
Elliott IA; Dann AM; Xu S; Kim SS; Abt ER; Kim W; Poddar S; Moore A; Zhou L; Williams JL; Capri JR; Ghukasyan R; Matsumura C; Tucker DA; Armstrong WR; Cabebe AE; Wu N; Li L; Le TM; Radu CG; Donahue TR
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):6842-6847. PubMed ID: 30894490
[TBL] [Abstract][Full Text] [Related]
60. Combined AURKA and H3K9 Methyltransferase Targeting Inhibits Cell Growth By Inducing Mitotic Catastrophe.
Mathison A; Salmonson A; Missfeldt M; Bintz J; Williams M; Kossak S; Nair A; de Assuncao TM; Christensen T; Buttar N; Iovanna J; Huebert R; Lomberk G
Mol Cancer Res; 2017 Aug; 15(8):984-997. PubMed ID: 28442587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
